Toggle navigation
Home
Search
Services
Blog
Contact
About
A Multiplexed Diagnostic Immunoassay for Clostridium Difficile and Antibiotic-Associated Diarrhea
Oliver, Kerry
Radix Biosolutions, Ltd, Georgetown, TX, United States
Search 5 grants from Kerry Oliver
Search grants from Radix Biosolutions, Ltd
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Ohio State University
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Host and symbiont determinants of colonization by a co-evolved gut community
Human Lung Regional Ventilation Defect Severity Measured by Fluorine-19 Gas MRI
Parent-Child Processes: Negative Self-Regulatory and Behavioral Outcomes
Stem Cell Therapies For Batten Disease
Regulation of the B-Cell Development and Differentiation
Recently added grants:
Characterizing the immune and metabolic profiles of cutaneous T-cell lymphoma in formalin-fixed paraffin-embedded skin tissue samples
Myeloid Syk promotes tumor immunosuppression and inhibits anti-tumor adaptive immunity
Targeting FTO to treat acute myeloid leukemia
Aberrant tumor metabolism that enables AR antagonist-resistant prostate cancer
Decoding the molecular basis of cellular identity in adult malignant gliomas
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Small Business Innovation Research – Phase II (N44)
Project #
272201500031C-0-0-1
Application #
9148107
Study Section
Project Start
2015-09-14
Project End
2017-09-13
Budget Start
Budget End
Support Year
Fiscal Year
2015
Total Cost
Indirect Cost
Institution
Name
Radix Biosolutions, Ltd
Department
Type
DUNS #
125250006
City
Georgetown
State
TX
Country
United States
Zip Code
78626
Related projects
NIH 2015
N44 AI
A Multiplexed Diagnostic Immunoassay for Clostridium Difficile and Antibiotic-Associated Diarrhea
Oliver, Kerry / Radix Biosolutions, Ltd
NIH 2015
N44 AI
Inhaled Drug Combination for Tuberculosis Therapy
Carter, Darrick / Pai Life Sciences, Inc.
Comments
Be the first to comment on Kerry Oliver's grant